| Dr Randall D Towne, MD | |
|
735 Mcfarland St, Morristown, TN 37814-3977 | |
| (423) 585-5567 | |
| (423) 585-4669 |
| Full Name | Dr Randall D Towne |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 43 Years |
| Location | 735 Mcfarland St, Morristown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750372751 | NPI | - | NPPES |
| 3860477 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20016 (Tennessee) | Primary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 20016 (Tennessee) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Vein Center Pllc | 2264727627 | 12 |
| Legacy Vein Center Pllc | 2264727627 | 12 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
| Entity Name | East Tennessee Heart Consultants, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740583541 PECOS PAC ID: 6608773163 Enrollment ID: O20031215000303 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
| Entity Name | Morristown Hamblen Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912997024 PECOS PAC ID: 1850201849 Enrollment ID: O20040209000526 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
| Entity Name | Parkwest Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396739165 PECOS PAC ID: 8527965417 Enrollment ID: O20040429000423 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
| Entity Name | Legacy Vein Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477972933 PECOS PAC ID: 2264727627 Enrollment ID: O20160824000796 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randall D Towne, MD Po Box 1298, Talbott, TN 37877-1298 Ph: (423) 585-5567 | Dr Randall D Towne, MD 735 Mcfarland St, Morristown, TN 37814-3977 Ph: (423) 585-5567 |
News Archive
Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.
Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Aetna is offering fully insured health plan customers, including Medicare members, in Ohio's Wood, Ottawa and Fulton counties an extra two months to make premium payments and file claims, among other assistance. People in those counties were affected by tornados and severe weather in early June.
Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).
› Verified 3 days ago
Syed Shaukat Husnain, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 850 W 3rd North St, Morristown, TN 37814 Phone: 423-581-2795 Fax: 423-581-7113 | |
Dr. Rodney O. Diehl, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 705 Mcfarland St, Morristown, TN 37814 Phone: 423-492-5450 | |
Orlanda Raymond Lowry Iii, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1432 Darbee Dr, Morristown, TN 37814 Phone: 423-581-3160 | |
Ifeoma Chiamaka Ogbuka, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 908 W 4th North St, Morristown, TN 37814 Phone: 773-701-2146 | |
Ernesto Mejia, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Mcfarland St, Suite B, Morristown, TN 37814 Phone: 423-587-0740 Fax: 423-581-0063 | |
Paul B Cardali, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 420 W Morris Blvd, Healthstar Physicians, Morristown, TN 37813 Phone: 423-586-0443 Fax: 423-586-0431 | |
David Arden Walker, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 850 W 3rd North St, Suite B, Morristown, TN 37814 Phone: 423-581-2795 Fax: 423-289-1605 |